Doctor Tuukka Tarvasmaki
Helsinki University Hospital, Helsinki (Finland)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Prognostic value of proenkephalin in mortality prediction in cardiogenic shock
Event: Heart Failure 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Acute Heart Failure – Epidemiology, Prognosis, Outcome
Hemodynamic alterations and 90-day mortality in cardiogenic shock complicated by acute kidney injury
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Prognosis (Syncope)
Session: Acute heart failure
Effect of baseline characteristics on mortality in the SURVIVE trial comparing levosimendan and dobutamine in acute heart failure: sub-analysis of the Finnish patients
Event: HEART FAILURE 2016
Topic: Acute heart failure (management)
Session: Acute heart failure
Adrenaline use is related to prominent deterioration in cardiac and renal biomarker profiles in cardiogenic shock
Event: HEART FAILURE 2016
Topic: Acute heart failure (other)
Session: Acute heart failure
Noradrenaline combined with either dobutamine or levosimendan - similar outcome and cardiac biomarker evolution in cardiogenic shock
Event: HEART FAILURE 2016
Topic: Acute heart failure (other)
Session: Rapid Fire 1 - Acute heart failure
